25.10.2020 • NewsAOC

AOC Buys Czech Resin Plant

US resins producer AOC has agreed with Czech company Spolchemie and its second largest shareholder Kaprain Investment Group to buy the unsaturated polyester resin (UPR) manufacturing operations at Usti nad Labem.

“This acquisition will give AOC a major leverage for strengthening our market position in Central and Eastern Europe, as well as in Germany. It enables us to ensure continued competitiveness in the region,” said AOC CEO Joe Salley.

AOC added that the new plant will also enable the manufacture of new products, such as those based on recycled PET for customers around Europe.

Spolchemie’s UPR plant has been making resins for AOC on a contract basis for many years and is said to have “unique capabilities” for producing green resins based on recycled PET.

The transfer of operations is expected to take effect as soon as possible during the current quarter.

Romana Benešová, CEO of Kaprain Investment, said the deal will enable Spolchemie to focus on its core business of chlorinated hydrocarbons and epoxy resins.

On Oct. 2, AOC also closed its purchase of Ashland’s maleic anhydride business and manufacturing facility in Neal, West Virginia, USA, for $100 million.

AOC plans to use some of the MA for its own internal consumption (for producing UPRs) and will also sell some volumes on the merchant market.

Author: Elaine Burridge, Freelance Journalist

 

US resins producer AOC has agreed with Czech company Spolchemie and its second...
US resins producer AOC has agreed with Czech company Spolchemie and its second largest shareholder Kaprain Investment Group to buy the unsaturated polyester resin (UPR) manufacturing operations at Usti nad Labem. The transfer is expected to take effect during the current quarter. (c) AOC

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.